Here are relevant reports on : digital-pharma-market

• Electronic Lab Notebook Market by Deployment (Cloud (SaaS, PaaS, IaaS)), License (Proprietary, Open source), Component (Software, Services), Organization Size (SME, Large), End User (Pharma & Biotech, NGS, Biobank, Academia) - Global Forecast to 2030

  Global electronic lab notebook market valued at $0.68B in 2024, reached $0.72B in 2025, and is projected to grow at a robust 7.3% CAGR, hitting $1.03B by 2030. The adoption of electronic lab notebooks (ELNs) is driven by the growing emphasis on laboratory digitization, the rising need for efficient data management, and integrated compatibility with advanced technologies. Additionally, the increasing use of ELNs within the life sciences sector is expected to fuel their adoption in the life sciences sector.

  • Published: May 2025
  • Price: $ 4950
  • TOC Available:

• Healthcare Hazmat Suits Market by type (heavy, light Protective Suits), End User (Hospitals, Research & Academic Institutes, Biotech & Pharma Companies)- Global Forecast to 2027

  The global Healthcare Hazmat Suits market size is projected to reach USD xx million by 2027 from USD xx million in 2022, at a CAGR of xx% during the forecast period.

  • Published: March 2026
  • Price: $ 4950
  • TOC Available:

• Protein Characterization Market / Protein Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectrometry), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery), End User (Pharma, Biotech, CROs) & Region - Global Forecast to 2026

  The global protein characterization market growth is primed to transition from $12.6 billion in 2021 to $23.9 billion by 2026, showcasing a strong CAGR of 13.7%. Growth in the protein identification market can mainly be attributed to factors such as rising acceptance of personalized medicine, technological advancement and increased drug discovery & development activities.

  • Published: September 2021
  • Price: $ 4950
  • TOC Available:

• Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023

  The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination. However, the high cost of enumeration instruments is expected to restrain market growth in the coming years. The bioburden testing market is competitive in nature, with the presence of several large and small players. Charles River (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), Becton, Dickinson and Company (US), NAMSA (US), Nelson Laboratories, LLC (US), Thermo Fisher Scientific (US), biomérieux SA (France), and Pacific BioLabs (US) are some of the leading payers in the bioburden testing market.

  • Published: December 2018
  • Price: $ 4950
  • TOC Available:

• Preclinical Imaging Market by Product (Optical Imaging (Bioluminescence), Nuclear Imaging (PET, SPECT), MRI, Reagents (Luciferins, Infrared Dyes), Software), Application (Onco, Cardio), End User (Pharma, Biotech, Academic, CRO) - Global Forecast to 2030

  The global preclinical imaging market, valued at US$3.36 billion in 2024, stood at US$3.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.5% from 2024 to 2030, culminating in a forecasted valuation of US$4.39 billion by the end of the period.

  • Published: December 2025
  • Price: $ 4950
  • TOC Available:

• Pharmaceutical Packaging Equipment Market by Product (Primary: Aseptic Filling and Sealing Equipment), Formulation (Liquid Packaging Equipment: Aseptic Liquid), Automation (Manual), End User (Pharma Manufacturing Companies) - Global Forecast to 2030

  The global pharmaceutical packaging equipment market, valued at US$9.75 billion in 2024, stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$14.3 billion by the end of the period. The pharmaceutical packaging equipment market is rapidly growing due to the increasing demand for accurate and high-quality diagnostic imaging, fueled by a rise in chronic diseases and an aging population.

  • Published: June 2025
  • Price: $ 4950
  • TOC Available:

• Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) & Region - Global Forecast to 2028

  The global leukapheresis market, valued at US$60 million in 2022, stood at US$70 million in 2023 and is projected to advance at a resilient CAGR of 8.3% from 2023 to 2028, culminating in a forecasted valuation of US$100 million by the end of the period. One of the key trends in the leukapheresis market is the increasing use of leukopaks in CAR T-cell therapy. CAR T-cell therapy is a type of immunotherapy that uses the patient's own immune cells to fight cancer.

  • Published: August 2023
  • Price: $ 4950
  • TOC Available:

• Healthcare Contract Management Software Market by Product & Service (Contract Lifecycle Management, Document Management), End User (Healthcare Providers, Hospitals, Physicians, Payers, Medical Device Manufacturers, Pharma) & Region - Global Forecasts to 2024

  The healthcare contract management software market is projected to reach USD 1,763 million by 2024, growing at a CAGR of 18.5%. The prominent players in this market are Determine Inc. (US), CobbleStone Software (US), Concord (US), Contract Logix LLC (US), Icertis (US), Apttus Corporation (US), Coupa Software Inc. (US), Optum Inc. (US), nThrive Inc. (US), Experian Plc. (Ireland), and ScienceSoft (US).

  • Published: June 2019
  • Price: $ 4950
  • TOC Available:

• Europe eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (Pharma, Biotech, Medtech), Opportunities, Trends, Market Share - Forecast to 2030

  The Europe eClinical solutions market, valued at US$2.82 billion in 2024, stood at US$3.18 billion in 2025 and is projected to advance at a resilient CAGR of 13.0% from 2025 to 2030, culminating in a forecasted valuation of US$5.86 billion by the end of the period. This growth is driven by the increasing shift toward digital and decentralized clinical trial models enabled by CTR and CTIS adoption.

  • Published: March 2026
  • Price: $ 4950
  • TOC Available:

• Protein Sequencing Market by Product (Sample Preparation, MS, Sequencer, Reagent, Consumable), Service, Technology (MS, Edman), Application (Biotherapeutics, Genetic Engineering), Enduser (Academia, Pharma, Biotechnology, CROs) - Global Forecasts to 2023

  The protein sequencing market is projected to reach USD 1,088 million by 2023, growing at a CAGR of 3.3%. Some of the prominent players in the protein sequencing market include Shimadzu (Japan), Thermo Fisher Scientific Inc. (US), SGS S.A. (Switzerland), Waters Corporation (US), Rapid Novor (Canada), Agilent Technologies (US), Charles River Laboratories (US) and Selvita (Poland).

  • Published: November 2018
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50